Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«

Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«:¼¡ÕÅÁ¦Õϰ­ÊÖÊõÌÛÂð

»áÔ±6086701 Òѻظ´
¼¡ÕÅÁ¦Õϰ­ÊÖÊõÌÛÂð
Ò½Éú»Ø´ð¹²1ÌõÒ½Éú»Ø¸´Òò²»ÄÜÃæÕҽÉúµÄ½¨Òé½ö¹©²Î¿¼
¹Ø×¢
ÂÀÖ¾ÇÚ Ö÷ÈÎҽʦ ±±¾©´óѧµÚÒ»Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾ÏÂÔØÄÚ¿Æ Èý¼¶¼×µÈ
É󤣺ÕïÖÎÄÔѪ¹Ü²¡¡¢¼¹ËèËðÉË¡¢×¶ÌåÍâϵ¼²²¡¡¢Éñ¾­¿ÆÒÉÄѲ¡...
ÃûÒ½¼«ËÙÎÊÕï
¼¡ÕÅÁ¦Õϰ­ÊÖÊõͨ³£ÌÛ¡£
¼¡ÕÅÁ¦Õϰ­ÊÇÖ÷¶¯¼¡ÓëÞ׿¹¼¡ÊÕËõ²»Ð­µ÷»ò¹ý¶ÈÊÕËõÒýÆðÀ´µÄÒÔ¼¡ÕÅÁ¦Òì³£µÄ¶¯×÷ºÍ×ËÊÆÎªÌØÕ÷µÄÔ˶¯Õϰ­×ÛºÏÕ÷,¾ßÓв»×ÔÖ÷ÐԺͳÖÐøÐÔµÄÌØµã¡£×öÊÖÊõµÄʱºò£¬×Ü»á¸Ð¾õµ½ÌÛÍ´¡£½¨Ò黼Õß»ý¼«Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«£¬±£³ÖÁ¼ºÃµÄÐÄ̬¡£±£³ÖÐÄÇéÊæ³©£¬Æ½Ê±¶àºÈË®£¬¶à³ÔÐÂÏʵÄÊß²ËË®¹û¡£Êõºó»¹Òª½øÐпµ¸´¶ÍÁ¶£¬ÓÐÀûÓÚ¼²²¡µÄ»Ö¸´¡£½¨Ò黼Õßµ½Õý¹æÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾ÏÂÔØ×öÈ«Ãæ¼ì²é£¬ÔÚÒ½ÉúÖ¸µ¼ÏÂÑ¡ÔñºÏÊʵÄÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«·½°¸¡£
Ïà¹ØÎÊ´ð

¼¡ÕÅÁ¦Õϰ­ÊÖÊõͨ³£ÌÛ¡£
¼¡ÕÅÁ¦Õϰ­ÊÇÖ÷¶¯¼¡ÓëÞ׿¹¼¡ÊÕËõ²»Ð­µ÷»ò¹ý¶ÈÊÕËõÒýÆðÀ´µÄÒÔ¼¡ÕÅÁ¦Òì³£µÄ¶¯×÷ºÍ×ËÊÆÎªÌØÕ÷µÄÔ˶¯Õϰ­×ÛºÏÕ÷,¾ßÓв»×ÔÖ÷ÐԺͳÖÐøÐÔµÄÌØµã¡£×öÊÖÊõµÄʱºò£¬×Ü»á¸Ð¾õµ½ÌÛÍ´¡£½¨Ò黼Õß»ý¼«Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«£¬±£³ÖÁ¼ºÃµÄÐÄ̬¡£±£³ÖÐÄÇéÊæ³©£¬Æ½Ê±¶àºÈË®£¬¶à³ÔÐÂÏʵÄÊß²ËË®¹û¡£Êõºó»¹Òª½øÐпµ¸´¶ÍÁ¶£¬ÓÐÀûÓÚ¼²²¡µÄ»Ö¸´¡£½¨Ò黼Õßµ½Õý¹æÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾ÏÂÔØ×öÈ«Ãæ¼ì²é£¬ÔÚÒ½ÉúÖ¸µ¼ÏÂÑ¡ÔñºÏÊʵÄÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«·½°¸¡£

ÂÀÖ¾ÇÚÖ÷ÈÎҽʦÄڿƱ±¾©´óѧµÚÒ»Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾ÏÂÔØ
É󤣺ÕïÖÎÄÔѪ¹Ü²¡¡¢¼¹ËèËðÉË¡¢×¶ÌåÍâϵ¼²²¡¡¢Éñ¾­¿ÆÒÉÄѲ¡Ö¢ºÍÉñ¾­ÐÄÀíÕϰ­¼²²¡¡£

¼¡ÕÅÁ¦Õϰ­»¼Õß²±×ÓÌÛ²»ÌÛÒª¿´»¼ÕߵľßÌåÇé¿ö£¬Èç¹û»¼ÕßÊǼ¡ÕÅÁ¦²»×ã¡¢ÖØÖ¢¼¡ÎÞÁ¦¡¢¸ñÁÖ°ÍÀû¡¢ÖÜΧÉñ¾­²¡µÈÔ­Òòµ¼ÖÂËÄÖ«¼¡ÕÅÁ¦Ï½µ£¬ÄÇô²±×ӾͲ»ÌÛÁË¡£Èç¹ûÊÇÅÁ½ðÉ­²¡ÒýÆðµÄ¼¡ÕÅÁ¦Ôö¸ß£¬ÓÐЩ»¼Õß¿ÉÄÜ»á³öÏÖËÄÖ«¼¡ÕÅÁ¦Ôö¸ß¡¢¾±²¿ÌÛÍ´µÈÖ¢×´£¬µ«Èç¹ûÊǾֲ¿¾±²¿¼¡ÈâµÄ¼¡ÕÅÁ¦Ôö¸ß£¬±ÈÈçËµÐØËøÈéÍ»¼¡ÊÕËõ¾·ÂΣ¬³öÏÖ¾·ÂÎÐÔб¾±£¬ÕâЩ»¼Õß¿ÉÄÜ»á±È½ÏÌÛ¡£»¹ÓÐһЩ»¼Õߣ¬È综ÕßÖ»ÊdzöÏÖ¾Ö²¿¼¡ÕÅÁ¦µÄ±ä»¯Õϰ­£¬Ò»°ã¶¼ÊÇÃæ¼¡ÑÛíú²¿¼¡ÈâµÄ¾·ÂΣ¬¾±²¿Ò»°ã²»»á¸Ðµ½ÌÛÍ´¡£

ÂÀÖ¾ÇÚÖ÷ÈÎҽʦÄڿƱ±¾©´óѧµÚÒ»Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾ÏÂÔØ
É󤣺ÕïÖÎÄÔѪ¹Ü²¡¡¢¼¹ËèËðÉË¡¢×¶ÌåÍâϵ¼²²¡¡¢Éñ¾­¿ÆÒÉÄѲ¡Ö¢ºÍÉñ¾­ÐÄÀíÕϰ­¼²²¡¡£

Ö¸µ¼Òâ¼û£ºÄãºÃ£¬¾±²¿¼¡ÕÅÁ¦Õϰ­Ò»°ã²»»áÓÐÍ·Í´µÄÖ¢×´µÄ¡£Äú˵ÕâÖÖÇé¿ö£¬ÓпÉÄÜÊÇѪ¹ÜÉñ¾­ÐÔÍ·ÌÛ£¬¿ÉÒÔ¿Ú·þ·Ò±ØµÃ£¬ÕýÌìÍèµÈÒ©Îï¶ÔÖ¢Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«£¬Òª×¢ÒâÐÝÏ¢£¬±£Ö¤³ä×ãÓÐЧµÄ˯Ãß¡£±ÜÃâ°¾Ò¹ºÍ¾«Éñ¹ý¶È½ôÕÅ¡£

Õź췼¸±Ö÷ÈÎҽʦÄڿƺӱ±ÒÕÊõְҵѧԺҽÎñÊÒ
É󤣺θ¡¢Ê®¶þÖ¸³¦À£Ññ,ÃÅÂöÐÔ¸ÎÓ²»¯,·´Á÷ÐÔʳ¹ÜÑ×,Þ²Âö¸ßѹÐÔθ²¡,¸ÎÓ²»¯,Ò©ÎïÐԸβ¡,¸ÎÐÔÄÔ²¡,ÃÖÂþÐÔʳ¹Ü¾·ÂÎ,êÚÃÅʧ³Ú»ºÖ¢,ÏÂÏû»¯µÀ³öѪ

Ö¸µ¼Òâ¼û£ºÄãºÃ£¬Ò»°ã¾±²¿¼¡ÕÅÁ¦Õϰ­²»»áÒýÆðÍ·Í´µÄ¡£Äã˵µÄÕâÖÖÇé¿ö£¬ÓпÉÄÜÊÇѪ¹ÜÉñ¾­ÐÔÍ·Í´£¬¿ÉÒÔ¿Ú·þ·Ò±ØµÃ£¬Î÷±ÈÁéµÈÒ©ÎïÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«£¬×¢ÒâÐÝÏ¢£¬±ÜÃâ°¾Ò¹ºÍ¾«Éñ¹ý¶È½ôÕÅ¡£¹Û²ìһϣ¬±ØÒªÊ±ÐèÒª×ö¾­Â­¶àÆÕÀÕ¼ì²é£¬ÅųýÄÔѪ¹Ü¹©Ñª²»×ãµÄ¿ÉÄÜ¡£

»ÆÊÀ²ý¸±Ö÷ÈÎҽʦÄڿƱ±¾©´óѧµÚÒ»Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾ÏÂÔØ
É󤣺Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«ÄÔѪ¹Ü²¡¼°ÇûÌåÐÎʽÕϰ­µÈÇéÐ÷ÐÔ¼²²¡

²¡Çé·ÖÎö£º ÄúºÃ£¬¶ÔÓÚÄúËù˵µÄÕâ¸öÒì³£µÄÖ¢×´±íÏÖÇé¿ö£¬Ò»°ãÊÇÊôÓÚÉñ¾­ÏµÍ³·½ÃæµÄ¼²²¡ÎÊÌâÒýÆð£¬´Ó¶øµ¼ÖÂÉÏÊöµÄÏÖÏó³öÏÖ£¬²»ÄÜÈ·ÕïΪ÷½Ü²¡£¬Ò»°ã¿ÉÒÔͨ¹ýÒ©ÎïÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«´¦Àí£¬½¨Òé¿ÉÒÔÍùÉñ¾­ÄڿƾÍÕï¼ì²é£¬ÔÚÒ½ÉúµÄ»áÕïÖ¸µ¼Ï½øÐÐÈ·ÕÔÙ½øÐÐÕë¶ÔÐÔµÄÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«´¦ÀíΪÒË¡£

»ÆÕ½ÎäÆäËûÏæÄÏѧԺ¸½ÊôÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾ÏÂÔØ
É󤣺Öз磬¹ÇÕÛÊõºóµÈ

Õó·¢ÐÔ¶¯×÷ÓÕ·¢Ô˶¯Õϰ­

[ÁÙ´²Ö¢×´]
»¼Õß»áÒòΪͻȻµÄ¶¯×÷¸Ä±ä¶ø²úÉú¶ÌÔݵļ¡ÕÅÁ¦²»È«(dystonia)»òÀàËÆÎ赸֢(choreo-like)¶¯×÷Õϰ­. ·¢×÷µÄÄê¼Í´ó²¿·Ö×ÔͯÄê»òÔçÆÚÇàÄ꿪ʼ, ÔÚHouser (1999) µÄÑо¿Öв¡»¼Æ½¾ùÄêÁäÔ¼13Ëê, ´ó²¿·Ö¶¼ÓмÒ×åÒÅ´«µÄÇãÏò(23%) , ÇÒÄÐÐÔ±ÈÅ®ÐÔ¶àÔ¼ 7:1. ¶øÔÚTomita (1999,ÈÕ±¾)µÄÑо¿ÖÐÆ½¾ùÄêÁäÔ¼8.8Ëê, 65%ÊǼÒ×åÒÅ´«ÐÔ, ÄÐÐÔ±ÈÅ®ÐÔ¶à,ԼΪ 4:1. µäÐ͵ķ¢×÷ÊÇÓÉͻȻµÄ¶¯×÷»ò×ËÊÆ¸Ä±ä(Èç×ø×Ë»»Õ¾×Ë,ÆðÉí¿ªÊ¼Åܲ½)¶ø²úÉú²»×ÔÖ÷µÄ¼¡ÕÅÁ¦²»È«»òÎ赸֢. ¾ªÏÅ»ò¹ý¶È»»Æø, Ðо¶ÖеÄËٶȱ仯(ÓÉÂý±ä¿ì),Ò²»áÓÕ·¢ÕâÑùµÄ¶¯×÷.ÔÚÍ£Ö¹µÄ״̬»ò˯ÃßÖÐÏÊÉÙ·¢×÷. ÓеIJ¡»¼»á¾õµÃÌìÆøÀä»ò½ôÕÅÊ±ÌØ±ðÈÝÒ×·¢×÷. ¾Æ¾«»ò¿§·È²¢²»»áʹ·¢×÷Ôö¼Ó. Ðí¶à²¡ÈËÔÚ·¢×÷ǰ¶¼ÓÐǰÕ×(aura),ÊÇÒ»ÖÖ¼¡È⿪ʼҪ±Á½ôµÄ¸Ð¾õ,°Ñ¶¯×÷·ÅÂý(warm up slowly)»òÕßÔÝÍ£¶¯×÷¿ÉÒÔÒÖÖÆ»ò×èÖ¹Æä·¢×÷. ÈôûÓа취ÒÖÖÆÊ±,ÕâÖÖ¼¡Èâ½ô±ÁµÄ¸Ð¾õ»á´ó²¿·Ö»á´Ó½Å²¿¿ªÊ¼(ÓÐʱҲ»á´ÓÊÖ¿ªÊ¼), ½ÓÖø¿ªÊ¼¼¡Èâ²»×ÔÖ÷Ô˶¯,ÂýÂýÑÓÉìµ½ÊÖ²¿»òÊÇÁ³²¿¶øÓйÖÒìµÄ±íÇé¼°¹¹ÒôÒì³£. ÑÏÖØÊ±»áÒòΪÎÞ·¨Î¬³Öƽºâ¶øµøµ¹,»òÉíÌåÂÍËõÔÚµØÉÏ,µ«·¢×÷ʱÒâʶ¶¼ÊÇÇå³þµÄ. ÓÐʱ²¡ÈË»á¾õµÃÓб»¼àÊӵĸоõ¶øÇÒ»á¸Ð¾õ½ôÕÅ. Dystonia³£³£Ó°ÏìÒ»±ßµÄÉíÌå,»òÊÇÁ½±ßͬʱ¿ªÊ¼, µ«ÊÇÒ²ÓеĻáÔÚ²»Í¬´Î·¢×÷»»±ß·¢×÷»òͬ´Î»»±ß·¢×÷. ·¢×÷µÄƵÂʲ»¹Ì¶¨,µ«Ò»Ìì×î¶à¿Éµ½ÊýÊ®´Î,³ÖÐøµÄʱ¼äÔ¼´ÓÊýÃëÖÓµ½2·ÖÖÓ,µ«ÏÊÉÙ³¬¹ý5·ÖÖÓ. ÔÚÁ½´Î·¢×÷ÖмäÓÐÒ»¶ÌÔݵIJ»·´Ó¦ÆÚ(refractory period )¶ø²»±»ÓÕ·¢.

[¼ì²é·½Ãæ]
Éñ¾­Ñ§¼ì²éÔÚûÓз¢×÷ʱÊÇÕý³£µÄ; ÄÔ²¨( Surface EEG) ÔÚ·¢×÷¼°Ã»Óз¢×÷ʱ¾ùÎÞÒì³£; Éñ¾­Ó°ÏñѧÕï¶Ï²¢ÎÞÌØ±ðÒì³£; Óб¨¸æÁ½Àý²¡»¼µÄautopsy²¢ÎÞÒì³£.

[Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«]
²¡È˾­ÓɵͼÁÁ¿µÄ¿¹ñ²ðïÒ©Îï¿É´ïµ½Ï൱ºÃµÄÁÆÐ§. ÆäÖÐÓÖÒÔ carbamazepine ΪÊ×Ñ¡ÓÃÒ©. ÔÚHouser et al ì¶1999ÄêµÄ±¨¸æÍ³¼ÆÔ¼ÓÐ78%µÄ²¡ÈË·¢×÷»áÏûʧ»òÏÔÖøµÄ¼õÉÙ. ÆäËûÈçOxcarbazepine(900mg/day) , Phenytoin(300mg/day) , Lamotrigen (100mg/day) µÈ¿¹ñ²ðïÒ©ÎïÒ²±»±¨¸æ¿ÉÓÐЧ¿ØÖÆ. µ«ÈôÍ£Ò©, Ö¢×´¿ÉÄÜÔÙ·¢. ÔÚPKDµÄ×ÔÈ»²¡³ÌÖз¢×÷µÄƵÂÊ»áËæÖøÄê¼Í¶ø¼õÉÙ, Óеı¨¸æ¹Û²ìµ½ÔÚÖÐÄêÒÔºóÓпÉÄÜ×Ô¼ºÈ¬Óú¶ø²»ÐèÒ©ÎïÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«.

Íõΰҽʦ¶ù¿ÆºÓ±±Ê¡°ÔÖÝÊÐÕý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾ÏÂÔØ
É󤣺С¶ùÍâ¿Æ
³£¼û¿ÆÊÒ¸ü¶à>
Õý°æ²¶ÓãÓÎÏ·(Öйú)app¹Ù·½ÏÂÔØ|Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾